Baxter Portfolio

$3 Billion

• BioPharmaceuticals
  • Recombinant
  • Plasma-Based

• Vaccines

• BioSurgery

• Transfusion Therapies

BioScience

$8 Billion Global Market Leader with Balanced and Complementary Portfolio

• Drug Delivery

• Infusion Systems

• Anesthesia

• Nutritional Products

• Oncology

$3 Billion

• Dialysis Products

• Dialysis Services

• Disease Management

• Organ Replacement

$2 Billion

Renal

Previous slide

Next slide

Back to first slide

View graphic version